2004
DOI: 10.1093/jac/dkh261
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacokinetic basis for the use of extended interval dosage regimens of gentamicin in neonates

Abstract: According to our pharmacokinetic population model, initial doses of gentamicin of 10 mg/kg, and dosage intervals between 36-48 h, appear to be appropriate to achieve target peak and trough serum levels of 15-20 and <0.5 mg/L, respectively, when extended-interval dosage regimens are implemented in newborns. The half-life of gentamicin in premature babies of very low weight and gestational age <31 weeks is long. Thus, to achieve serum concentrations in the 1-10 mg/L range, the use of dosage regimens of 5 mg/kg a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

6
58
1
2

Year Published

2006
2006
2020
2020

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 48 publications
(67 citation statements)
references
References 24 publications
6
58
1
2
Order By: Relevance
“…This drug has a long t 1/2 and a large Vd, especially in premature infants [21]. The same applies to the other aminoglycosides.…”
Section: Discussionmentioning
confidence: 84%
See 4 more Smart Citations
“…This drug has a long t 1/2 and a large Vd, especially in premature infants [21]. The same applies to the other aminoglycosides.…”
Section: Discussionmentioning
confidence: 84%
“…There is a remarkable variation in the pharmacokinetic parameters of gentamicin [21,50], netilmicin [30][31][32]38], tobramycin [39,40] and amikacin [51,52]. Such a variation is due to renal maturation [50] as aminoglycosides are fairly water soluble and are eliminated with the urine.…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations